Sanofi Plans to Cut the Price of Insulin
The company is the third of the three major insulin manufacturers that dominate the U.S. market to announce such a move this month.
F.D.A. Advisers Endorse Paxlovid’s Benefits as a Covid Treatment
While an agency analysis did find signs of Covid “rebound,” the drug significantly reduces hospitalizations and deaths, researchers said.
What to Know About the Recent Eye Drop Recalls
Global Pharma recalled eye drops in February after they were tied to a drug-resistant bacteria strain linked to at least one death. Two more companies have since recalled eye drops.
Biden Looks to Bolster Support Among Seniors With a Focus on Health Care
In a trip to Las Vegas, President Biden warned that Republicans would endanger popular programs like Social Security and Medicare.
Texas Judge Hears Case to End Federal Approval of Abortion Pill
The judge said he would decide soon whether to issue a preliminary injunction ordering the F.D.A. to withdraw its approval of the drug or wait for the full trial.
Novo Nordisk Says It Will Slash the Price of Insulin
The company’s decision follows a similar move by its rival, Eli Lilly, this month.
How an Opioid Settlement Hinders Patients’ Access to ADHD Medication and Other Drugs
An agreement between attorneys general and major drug distributors increased scrutiny on medications for A.D.H.D., addiction, anxiety and pain.
Judge in Abortion Pill Case Set Hearing but Sought to Delay Telling the Public
Saying he wanted safe and orderly proceedings, Judge Matthew J. Kacsmaryk asked lawyers not to disclose the hearing and planned to add it to the public case file only the evening before.
¿Podría el próximo fármaco de éxito conseguirse sin ratas de laboratorio?
Las alternativas a los ensayos con animales están ganando terreno.
F.D.A. Approves New Nasal Spray for Migraines
Pfizer’s treatment applies an approach that is different from some other products, which doctors say may make it safer for people at risk of heart attacks or stroke.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.